E
1.85
-0.12 (-6.09%)
| Previous Close | 1.97 |
| Open | 1.90 |
| Volume | 43,364 |
| Avg. Volume (3M) | 34,587 |
| Market Cap | 158,205,520 |
| Price / Book | 8.75 |
| 52 Weeks Range | |
| Earnings Date | 26 Feb 2025 - 3 Mar 2025 |
| Profit Margin | -24.33% |
| Operating Margin (TTM) | -56.27% |
| Diluted EPS (TTM) | -0.030 |
| Quarterly Revenue Growth (YOY) | 125.40% |
| Total Debt/Equity (MRQ) | 15.66% |
| Current Ratio (MRQ) | 6.41 |
| Operating Cash Flow (TTM) | -5.99 M |
| Levered Free Cash Flow (TTM) | -4.39 M |
| Return on Assets (TTM) | -7.95% |
| Return on Equity (TTM) | -23.10% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (AU) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | EMVISION FPO [EMV] | - | - |
AIStockmoo Score
1.6
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | 4.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -0.5 |
| Average | 1.63 |
|
EMvision Medical Devices Ltd is an Australian medical device company. The company is focused on the research and development and commercialisation of neurodiagnostic technology for stroke diagnosis and monitoring, as well as other medical imaging needs. Its focus is portable, cost effective and non-invasive brain scanners, including a bedside device (emu) and an ultra-light weight first responder pre-hospital device. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Growth |
| % Held by Insiders | 35.88% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |